Precision-medicine startup using epiproteomics and AI to predict treatment response.
| Date | Round | Amount |
|---|---|---|
| Dec 2024 | Seed Tel Aviv-based Promise Bio emerged from stealth with an 8.3M USD seed led by Awz Ventures to develop its AI epiproteomics platform. | $8.3M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.